Stocks and Investing Stocks and Investing
Mon, July 15, 2019
Fri, July 12, 2019
Thu, July 11, 2019

Randall Stanicky Downgraded (AMRX) to Hold and Decreased Target to $6 on, Jul 11th, 2019


Published on 2024-10-26 14:38:51 - WOPRAI, Randall Stanicky
  Print publication without navigation


Randall Stanicky of RBC Capital, Downgraded "Amneal Pharmaceuticals, Inc." (AMRX) to Hold and Decreased Target from $11 to $6 on, Jul 11th, 2019.

Randall has made no other calls on AMRX in the last 4 months.



There is 1 other peer that has a rating on AMRX. Out of the 1 peers that are also analyzing AMRX, all agrees with Randall's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gary Nachman of "BMO Capital" Maintained at Hold with Decreased Target to $13 on, Friday, May 10th, 2019
Contributing Sources